Allergan PLC (NYSE: AGN) finally has announced that its shareholders have voted to approve the company’s acquisition by AbbVie Inc. (NYSE: ABBV). The acquisition is expected to close in early 2020, but it is still subject to customary closing conditions and regulatory approvals.
AbbVie will acquire Allergan in a cash and stock transaction for a transaction equity value of roughly $63 billion, based on the closing price of AbbVie’s common stock of $78.45 on June 24, 2019.
Under the terms of the agreement, Allergan shareholders will receive 0.8660 AbbVie shares and $120.30 in cash for each Allergan share, for a total consideration of $188.24 per Allergan share.
The transaction price of $188.24 per share implies an upside of 15% from the 50-day moving average ($168.85) and 26.5% from the 200-day moving average ($148.69).
Brent Saunders, board chair and chief executive of Allergan, commented:
On behalf of Allergan’s Board of Directors and executive team, I would like to thank our shareholders for their overwhelming support of the proposed combination with AbbVie. In addition to delivering value for shareholders, this combination will create a leading biopharmaceutical company with a diversified portfolio and enhanced opportunity to invest in and deliver innovation for the patients we serve.
Shares of Allergan traded relatively flat at $168.80 Monday morning, in a 52-week range of $114.27 to $192.69. The consensus price target is $183.40.
AbbVie traded at $73.50. It has a 52-week range of $62.66 to $94.98 and a consensus price target of $88.91.
Take This Retirement Quiz To Get Matched With A Financial Advisor (Sponsored)
Take the quiz below to get matched with a financial advisor today.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the
advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Take the retirement quiz right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
